Participant | Sex | Age (yrs) | Neuropsychological Testing | Speech-Language Abilities | Medications (daily dosage) |
---|---|---|---|---|---|
P1_LFA | M | 17 | ADOS Module 1 (composite score 21); PPVT-IV-B (score 20)† | Nonverbal | Vitamins; digestive enzymes |
P2_LFA | M | 25 | ADOS Module 2 (composite score 23); KBIT-2 (composite IQ 44); PPVT-IV-B (score 36) | Minimally verbal | Risperidone (1mg); Cetirizine (10mg); Lithium (1500 mg) |
P3_LFA | M | 39 | ADOS Module 4 (composite score 22); KBIT-2 (composite IQ 61); PPVT-IV-B (score 58) | Minimally verbal: single words only; monotonic | Sertraline (50mg), Clomipramine (50mg) |
P4_LFA | M | 48 | ADOS Module 4 (composite score 19); KBIT-2 (composite IQ 112); PPVT-IV-B (score 94) | Minimally verbal: single words only; aversion to /pl/ and other speech sounds | Sertraline (100mg); Amlodipine (5mg) |
P5_LFA | M | 28 | ADOS Module 4 (composite score 18); KBIT-2 (composite IQ 66); PPVT-IV-B (score 62) | Minimally verbal | Loratadine (10mg) |
P6_LFA | F | 26 | ADOS Module 4 (composite score 19); KBIT-2 (composite IQ 64); PPVT-IV-B (score 45) | Minimally verbal | NA |
P7_HFA | M | 26 | ADOS Module 4 (composite score 14); KBIT-2 (composite IQ 77); PPVT-IV-B (score 71) | Verbal | NA |
P8_HFA | M | 26 | ADOS Module 4 (composite score 10); KBIT-2 (composite IQ 129); PPVT-IV-B (score 136) | Verbal | Duloxetine (30mg) |
P9_HFA | F | 21 | ADOS Module 4 (composite score 14); KBIT-2 (composite IQ 80); PPVT-IV-B (score 88) | Verbal | NA |
P10_HFA | M | 45 | ADOS Module 4 (composite score 10); KBIT-2 (composite IQ 144); PPVT-IV-B (score 137) | Verbal | Ropinirole (dosage undisclosed) |
P11_HFA | M | 30 | ADOS Module 4 (composite score 10); KBIT-2 (composite IQ 89); PPVT-IV-B (score 98) | Verbal | NA |
P12_HFA | M | 27 | ADOS Module 4 (composite score 18); KBIT-2 (composite IQ 103); PPVT-IV-B (score 116) | Verbal | Sertraline (200mg); Quetiapine (200mg) |
P13_TD | M | 26 | NA | Verbal | NA |
P14_TD | M | 25 | NA | Verbal | NA |
P15_TD | M | 28 | NA | Verbal | NA |
P16_TD | M | 22 | NA | Verbal | NA |
P17_TD | F | 20 | NA | Verbal | NA |
P18_TD | M | 35 | NA | Verbal | NA |